CLINICAL_TRIALS
trial_result
· 2018-08-15
Clinical Trial Update: Imiquimod Treatment of CIN Lesions [Phase 3]
Summary
Phase 3 clinical trial update for imiquimod in treating cervical intraepithelial neoplasia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maastricht University Medical Center | Conditions: Cervical Intraepithelial Neoplasia | Phase 3 | Status: TERMINATED